Poxel S.A.
PXXLFOTCHealthcare
$0.26
+$0.00(+0.00%)
Market Cap$15876379
P/E Ratio—
52W High$0.7
52W Low$0.25
Poxel S.A. (PXXLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PXXLF · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2025Report Date: Jun 30, 2025EPS Actual
-$0.59
Revenue
$0.01B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Jun 30, 2025
After Market Close
✓ 1-Quarter EPS Beat Streak
PXXLF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 23, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Sep 23, 2026 | — | — | — | — | — | — |
| — Q2 FY2025 | Jun 30, 2025 | — | -$0.59 | — | $0.01B | — | — |
| — Q2 FY2025 | Apr 22, 2025 | — | -$0.28 | — | $0.01B | — | — |
| — Q4 FY2024 | Dec 9, 2024 | — | -$0.18 | — | $0.00B | — | — |
| ▲ Q2 FY2024 | Jun 20, 2024 | -$0.42 | -$0.31 | +26.9% | $0.00B | $0.00B | +182.4% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -$0.46 | -$0.90 | -96.9% | $0.00B | $0.00B | -36.3% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -$0.25 | -$0.66 | -169.8% | $0.00B | $0.00B | -0.9% |
Q3 FY2026
Sep 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Sep 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 30, 2025
EPS Actual
-$0.59
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q2 FY2025
Apr 22, 2025
EPS Actual
-$0.28
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Dec 9, 2024
EPS Actual
-$0.18
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 20, 2024Beat
EPS Actual
-$0.31
EPS Est.
-$0.42
EPS Surpr.
+26.9%
Revenue
$0.00B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
-$0.90
EPS Est.
-$0.46
EPS Surpr.
-96.9%
Revenue
$0.00B
Q4 FY2022
Dec 31, 2022Miss
EPS Actual
-$0.66
EPS Est.
-$0.25
EPS Surpr.
-169.8%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $-0.37 | $-0.37 | $-0.37 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Jun 30, 2025 | — | $0.25 | $0.25 | +0.00% |
| — Q2 FY2025 | Apr 22, 2025 | — | $0.25 | $0.25 | +0.00% |
| — Q4 FY2024 | Dec 9, 2024 | — | $0.25 | $0.25 | +0.00% |
| ▲ Q2 FY2024 | Jun 20, 2024 | +26.9% | $0.70 | $0.70 | +0.00% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -96.9% | $2.60 | $2.60 | +0.00% |
| ▼ Q4 FY2022 | Dec 31, 2022 | -169.8% | $2.60 | $2.60 | +0.00% |
| ▲ Q4 FY2022 | Oct 4, 2022 | +27.8% | $2.60 | $2.60 | +0.00% |
| ▲ Q2 FY2022 | May 17, 2022 | +44.1% | $2.10 | $2.10 | +0.00% |
Q2 FY2025+0.00%
Report Date
Jun 30, 2025
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q2 FY2025+0.00%
Report Date
Apr 22, 2025
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q4 FY2024+0.00%
Report Date
Dec 9, 2024
EPS Beat/Miss
—
Price Before
$0.25
Price After
$0.25
Q2 FY2024+0.00%
Report Date
Jun 20, 2024
EPS Beat/Miss
+26.9%
Price Before
$0.70
Price After
$0.70
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
-96.9%
Price Before
$2.60
Price After
$2.60
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
-169.8%
Price Before
$2.60
Price After
$2.60
Q4 FY2022+0.00%
Report Date
Oct 4, 2022
EPS Beat/Miss
+27.8%
Price Before
$2.60
Price After
$2.60
Q2 FY2022+0.00%
Report Date
May 17, 2022
EPS Beat/Miss
+44.1%
Price Before
$2.10
Price After
$2.10
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate3 / 8 quarters
Largest Move+0.00% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PXXLF ends December
Poxel S.A. (PXXLF) most recently reported earnings on June 30, 2025 for Q2 FY2025, posting EPS of $-0.59 (in line with the analyst consensus of —).
Each quarter, investors track PXXLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PXXLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PXXLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PXXLF earnings · 4 questionsPoxel S.A.'s next earnings report is expected around TBD. PXXLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PXXLF historically reports after market close (AMC).
PXXLF earnings datewhen is PXXLF earningsPXXLF next earnings datewhen does PXXLF report earningsPXXLF earnings calendar
▸ Source: FMP · Poxel S.A. SEC filings · US GAAP · Poxel S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026